Policy of Funding Advances and Capital Expenditures with Internal Funds
First written in FY2019. . Latest entry: FY2026.
36 other companies' latest entry also says "Other".
- FY2026Updated capital expenditure record funded with internal fundsAnnual report
「In addition, total capital expenditures made during the consolidated fiscal year amounted to ¥136.077 million, and were funded with internal funds, including other expenses.」
The policy of funding advances and capital expenditures with internal funds was reconfirmed, and capital expenditures of ¥136.077 million during the period were funded with internal funds. - FY2022Updated capital expenditure record funded with internal fundsAnnual report
「In addition, total capital expenditures made during the fiscal year amounted to ¥95.591 million, and were funded with internal funds, including other expenses.」
The policy of funding advances required for subrogation payments with internal funds was reconfirmed, and capital expenditures of ¥95.591 million funded with internal funds were disclosed. - FY2021Updated capital expenditure record funded with internal fundsAnnual report
「These advances are funded with internal funds. In addition, total capital expenditures made during the fiscal year amounted to ¥121.887 million, and were funded with internal funds, including other expenses.」
The policy of funding advances associated with subrogation payments with internal funds was reconfirmed, and capital expenditures funded with internal funds increased from ¥100.001 million in the previous fiscal year to ¥121.887 million. - FY2020Updated capital expenditure record funded with internal fundsAnnual report
「In addition, total capital expenditures made during the fiscal year amounted to ¥100.001 million, and were funded with internal funds, including other expenses.」
The policy and track record of funding advances required for subrogation payments and ¥100.001 million in capital expenditures with internal funds were reconfirmed. - FY2019First statedAnnual report
「In its guarantee business, the company incurs certain advances in making subrogation payments, and these advances are funded with internal funds. In addition, total capital expenditures made during the fiscal year amounted to ¥57.047 million, and were funded with internal funds, including other expenses.」
A policy of funding advances associated with subrogation payments and capital expenditures with internal funds was presented in a form suitable for thread creation for the first time.